A cell-based flu vaccine was developed as an alternative to the egg-based manufacturing process. Scientists at each of the five main centers then gather and analyze the data together to identify new flu strains and to determine which strains of the virus are most likely to spread and cause illness in the upcoming flu season.… Read More »
According to the Center for Disease Control, Zostavax is a medication that was licensed in 2006 to treat shingles. It is administered through a shot and only one dose is given to protect individuals from acquiring shingles. While the product is marketed as a safeguard against the shingles virus, the vaccine has caused adverse effects… Read More »
Dec. 28, 2018 — The FDA has approved a new vaccine to immunize children against diphtheria, tetanus, pertussis (also known as whooping cough), hepatitis B, polio, and an invasive disease caused by Haemophilus influenzae type b, sometimes known as Hib. The vaccine will be for children 6 weeks to 4 years old. All will require… Read More »
A global coalition set up to fight disease epidemics is investing up to $ 8.4 million to develop a synthetic vaccine system that could be tailor-made to fight multiple pathogens such as flu, Ebola, Marburg and Rabies. The deal, between the Coalition for Epidemic Preparedness Innovations (CEPI) and a team of scientists at Britain’s Imperial… Read More »